Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment

Oncogene
Luke BuTakatsugu Ishimoto

Abstract

Increasing lines of evidence show that the malignant behavior of cancer is not exclusively attributable to cancer cells but also radically influenced by cancerous stroma activity and controlled through various mechanisms by the microenvironment. In addition to structural components, such as the extracellular matrix, stromal cells, such as macrophages, endothelial cells, and specifically cancer-associated fibroblasts (CAFs), have attracted substantial attention over recent decades. CAFs provide routes for aggressive carcinomas and contribute to invasion and metastasis through the biochemical alteration and regulation of cancer-related pathways. However, another facet of CAFs that has been neglected by numerous studies is that CAFs might serve as a negative regulator of cancer progression under certain circumstances. The various origins of CAFs, the diverse tissues in which they reside and their interactions with different cancer cells appear to be responsible for this inconsistency. This review summarizes the latest knowledge regarding CAF heterogeneity and offers a novel perspective and a beneficial approach for obtaining an improved understanding of CAFs.

References

Jun 15, 1986·International Journal of Cancer. Journal International Du Cancer·S L SchorD Crowther
Jul 1, 1995·The Journal of Cell Biology·F StrutzE G Neilson
May 18, 2001·Nature·L A Liotta, E C Kohn
Sep 13, 2001·Molecular Biology of the Cell·B HinzC Chaponnier
Sep 26, 2002·Proceedings of the National Academy of Sciences of the United States of America·Howard Y ChangPatrick O Brown
Jan 28, 2003·The American Journal of Pathology·Ole William PetersenLone Rønnov-Jessen
Apr 3, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Olivier De WeverMarc Mareel
May 11, 2004·Oncogene·Teresa Ramirez-MontagutAlan N Houghton
Jul 12, 2005·Nature Genetics·Min HuKornelia Polyak
Mar 31, 2006·Nature Reviews. Cancer·Raghu Kalluri, Michael Zeisberg
Aug 2, 2006·Cell Cycle·Akira Orimo, Robert A Weinberg
Jan 4, 2007·The Journal of Clinical Investigation·M Bishr OmaryStephen J Pandol
Feb 17, 2007·International Journal of Cancer. Journal International Du Cancer·Eun-Jung JungSoon-Tae Park
Oct 5, 2007·Nature·Antoine E KarnoubRobert A Weinberg
Dec 8, 2007·Journal of Cellular Physiology·Taro MatsumotoHideo Mugishima
Jun 12, 2008·International Journal of Cancer. Journal International Du Cancer·Akikazu KawaseAtsushi Ochiai
Jul 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elinborg OstermannGuenther R Adolf
Sep 4, 2008·International Journal of Cancer. Journal International Du Cancer·Sebastián GiulianelliClaudia Lanari
Sep 9, 2008·International Journal of Cancer. Journal International Du Cancer·Olivier De WeverMarc Bracke
Oct 3, 2008·Cancer Research·Rebecca MarlowLindsay Hinck
May 5, 2009·The American Journal of Pathology·Agnieszka K WitkiewiczMichael P Lisanti
Oct 23, 2009·Nature·Anthony J TrimboliGustavo Leone
Mar 10, 2010·Experimental Cell Research·Kristian Pietras, Arne Ostman
Mar 27, 2010·International Journal of Cancer. Journal International Du Cancer·Marilena VeredTuula Salo

❮ Previous
Next ❯

Citations

Sep 9, 2019·Cancer Science·Shamaine Wei Ting Ho, Patrick Tan
Jan 16, 2020·Cancers·Anzhelika KarjalainenMathias Müller
Feb 27, 2020·Nature Reviews. Gastroenterology & Hepatology·Harry Cheuk Hay LauJun Yu
Nov 7, 2019·Biochemistry. Biokhimii︠a︡·E D Sverdlov, I P Chernov
Aug 3, 2019·International Journal of Molecular Sciences·Sabino RussiVitalba Ruggieri
Dec 4, 2019·Frontiers in Oncology·Kendall L LangstenJaime F Modiano
May 28, 2020·Cancers·Stefano FregaLaura Evangelista
Jun 6, 2020·Frontiers in Immunology·Alireza Labani-MotlaghAngelica Loskog
Jun 4, 2020·International Journal of Molecular Sciences·Sarah OuahoudLukas J A C Hawinkels
Sep 15, 2020·Frontiers in Cell and Developmental Biology·Nicolas ClereIsabelle Corre
Oct 30, 2020·Cancers·Kévin LouaultYves A DeClerck
Dec 18, 2020·Frontiers in Cell and Developmental Biology·Armel H Nwabo KamdjeMauro Krampera
Feb 26, 2021·Frontiers in Immunology·Russell FoxallMark S Cragg
Feb 19, 2021·Regenerative Therapy·Tadahito YasudaHideo Baba
Mar 14, 2021·Cancer Gene Therapy·Qinrong PingRuhong Li
Jun 4, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Yue CaoNa Lu
Mar 16, 2021·Frontiers in Oncology·Claire Deligne, Kim S Midwood
Mar 26, 2021·Seminars in Liver Disease·Haichuan WangXin Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
SMA
acetylation
xenografts
xenograft
transgenic

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.